Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 296 Records) |
| Query Trace: Recurrence and Egfr[original query] |
|---|
| Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-oncology 2023 9 . Steven Tobochnik, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo L |
| The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer. Cancer medicine 2023 9 . Takayuki Honda, Katsutoshi Seto, Satoshi Endo, Akira Takemoto, Kousuke Tanimoto, Masashi Kobayashi, Masatake Kitano, Rie Sakakibara, Takahiro Mitsumura, Hironori Ishibashi, Johji Inazawa, Toshihiro Tanaka, Yasunari Miyazaki, Kenichi Oku |
| EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
| Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer. Frontiers in oncology 2023 7 13 1116809. Qiyu Fang, Xiaoying Wan, Angelica D'Aiello, Hui Sun, Weiquing Gu, Yixue Li, Caicun Zhou, Boxiong Xie, Qinfang Deng, Haiying Cheng, Songwen Zh |
| Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma. Cancer research and treatment 2023 7 . Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Sh |
| Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC. The New England journal of medicine 2023 6 . Masahiro Tsuboi, Roy S Herbst, Thomas John, Terufumi Kato, Margarita Majem, Christian Grohé, Jie Wang, Jonathan W Goldman, Shun Lu, Wu-Chou Su, Filippo de Marinis, Frances A Shepherd, Ki Hyeong Lee, Nhieu Thi Le, Arunee Dechaphunkul, Dariusz Kowalski, Lynne Poole, Ana Bolanos, Yuri Rukazenkov, Yi-Long Wu, |
| Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations. Genes 2023 6 14 (6): . Yong Gon Cho, Joonhong Park, Ji Yoon Han, Tae Yun K |
| Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer. Anticancer research 2023 6 43 (7): 3247-3253. Hidenori Suzuki, Eiichi Sasaki, Tsuneo Tamaki, Takeshi Kodaira, Masami Nishio, Daisuke Nishikawa, Shintaro Beppu, Hoshino Terada, Michi Sawabe, Nobuhiro Han |
| The prognostic impact of epidermal growth factor receptor mutation in clinical stage I lung adenocarcinoma. The Annals of thoracic surgery 2023 6 . Fujun Yang, Ke Sun, Fei Li, Xiang Li, Jinghan Shi, Xiwen Sun, Yong Hong, Gening Jiang, Yuming Zhu, Xiao So |
| An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma. PloS one 2023 6 18 (6): e0287256. Yeseul Kim, Bokyung Ahn, Shinkyo Yoon, Goeun Lee, Deokhoon Kim, Sung-Min Chun, Hyeong-Ryul Kim, Se Jin Jang, Hee Sang Hwa |
| Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stage I-IIIA EGFR Mutant-Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 6 . Hyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Yoon-La Choi, Sun Hye Shin, Byeong-Ho Jeong, Sang-Won Um, Hojoong Kim, Kyunga Kim, Myung-Ju Ahn, Jhingook K |
| Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
| Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer. Journal of cancer research and therapeutics 2023 5 19 (Supplement): S183-S190. Berna Komurcuoglu, Gamze Karakurt, Ozge O Kaya, Gulden Diniz, Ozgür K?rb?y?k, Aysen Evkan, Enver Yaln |
| T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma. Tanaffos 2023 4 21 (3): 376-383. Mirtavoos-Mahyari Hanifeh, Abbasi Dezfouli Azizollah, Esfahani-Monfared Zahra, Khosravi Adnan, Seifi Sharareh, Sheikhy Kamb |
| Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma. BMC cancer 2023 3 23 (1): 248. Ito Masaoki, Miyata Yoshihiro, Kushitani Kei, Ueda Daisuke, Takeshima Yukio, Okada Morihi |
| Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation. The oncologist 2023 3 . Hou Zhiwei, Wu Huaguo, Luo Ningning, Li Shuo, Zhang Xiang, Dong Shuai, Zhu Dongyuan, Zhang Hui, Tao Rongj |
| Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma. The Annals of thoracic surgery 2023 2 . Kamigaichi Atsushi, Mimae Takahiro, Tsubokawa Norifumi, Miyata Yoshihiro, Adachi Hiroyuki, Shimada Yoshihisa, Ito Hiroyuki, Ikeda Norihiko, Okada Morihi |
| Different prognostic role of EGFR mutation according to the IASLC histologic grade in patients with resected early-stage lung adenocarcinoma. Histopathology 2023 2 . Hong Tae Hee, Hwang Soohyun, Choi Yoon-La, Lee Genehee, Park Sehhoon, Ahn Myung-Ju, Lee Yoonseo, Jeon Yeong Jeong, Lee Junghee, Shin Sumin, Park Seong Yong, Cho Jong Ho, Choi Yong Soo, Kim Jhingook, Shim Young Mog, Cho Juhee, Kim Hong Kw |
| Efficacy of adjuvant chemotherapy in stage II/III NSCLC with EGFR mutation. The Thoracic and cardiovascular surgeon 2023 2 . Matsunaga Takeshi, Takamochi Kazuya, Hattori Aritoshi, Fukui Mariko, Suzuki Ken |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
| Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO precision oncology 2023 2 7 e2200465. Ardeshir-Larijani Fatemeh, Schneider Bryan P, Althouse Sandra K, Radovich Milan, Masood Ashiq, Perna Fabiana, Salman Huda, Loehrer Patrick |
| Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma. Interdisciplinary cardiovascular and thoracic surgery 2023 11 37 (5): . Yuki Matsumura, Kazuki Hayasaka, Tetsuya Ohira, Satoshi Shiono, Jiro Abe, Hirotsugu Notsuda, Akira Sakurada, Hiroyuki Suzuki, Yoshinori Oka |
| Prognostic Outcomes and Recurrence Patterns in Resected Stage I Lung Adenocarcinoma Harboring Atypical Epidermal Growth Factor Receptor Mutation. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2023 11 . Tao Chen, Jialiang Wen, Yingze Li, Jiajun Deng, Yifan Zhong, Likun Hou, Yunlang She, Dong Xie, Chang Ch |
| Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation. Clinical lung cancer 2023 11 . Kazuki Hayasaka, Haruna Takeda, Akira Sakurada, Yuki Matsumura, Jiro Abe, Satoshi Shiono, Hirotsugu Notsuda, Hiroyuki Suzuki, Makoto Endo, Hozumi Motohashi, Yoshinori Oka |
| Air bronchogram on chest CT in radiological pure-solid appearance lung cancer: Correlation analysis with genetic pathological features and survival outcomes. European journal of radiology 2023 11 169 111194. Zijian Wang, Wei Zhu, Menghang Yang, He Du, Fei Zhou, Nan Song, Ziwei Wan, Jingqi Zhu, Wei |
| Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence. Diagnostics (Basel, Switzerland) 2023 10 13 (20): . Seong Hyeon Yu, Sung Sun Kim, Hyungki Lee, Shinseung Kim, Taek Won Ka |
| Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8902-8915. Michael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, Sotirios P Fortis, Nikolaos Kesesidis, Christos Kakouratos, Ioannis Karakasiliotis, Constantin N Baxevan |
| Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model. Open life sciences 2023 10 18 (1): 20220705. Bo Liu, Shaofeng Zhang, Chunyan Liu, Xia H |
| Adjuvant therapy in completely resected, EGFR-mutant non-small cell lung cancer: a comparative analysis of treatment efficacy between EGFR-TKI and anti-PD-1/PD-L1 immunotherapy. Journal for immunotherapy of cancer 2023 10 11 (10): . Zichun Li, Xuanye Zhang, Yuhong Wang, Zhixin Yu, Chunlong Yang, Yixin Zhou, Shaodong Ho |
| Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 1 JCO2202186. Herbst Roy S, Wu Yi-Long, John Thomas, Grohe Christian, Majem Margarita, Wang Jie, Kato Terufumi, Goldman Jonathan W, Laktionov Konstantin, Kim Sang-We, Yu Chong-Jen, Vu Huu Vinh, Lu Shun, Lee Kye Young, Mukhametshina Guzel, Akewanlop Charuwan, de Marinis Filippo, Bonanno Laura, Domine Manuel, Shepherd Frances A, Urban Damien, Huang Xiangning, Bolanos Ana, Stachowiak Marta, Tsuboi Masahi |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: